Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients

Cell Mol Immunol. 2020 Sep;17(9):992-994. doi: 10.1038/s41423-020-0492-x. Epub 2020 Jul 3.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Kidney Injury / complications
  • Acute Kidney Injury / diagnosis*
  • Acute Kidney Injury / mortality
  • Acute Kidney Injury / virology
  • Betacoronavirus / pathogenicity*
  • Biomarkers / blood
  • COVID-19
  • Calgranulin A / blood*
  • Calgranulin B / blood*
  • Case-Control Studies
  • China
  • Coronavirus Infections / complications
  • Coronavirus Infections / diagnosis*
  • Coronavirus Infections / mortality
  • Coronavirus Infections / virology
  • Cytokine Release Syndrome / complications
  • Cytokine Release Syndrome / diagnosis*
  • Cytokine Release Syndrome / mortality
  • Cytokine Release Syndrome / virology
  • HMGB1 Protein / blood
  • HMGB1 Protein / genetics
  • Humans
  • Intensive Care Units
  • Lymphocytes / pathology
  • Lymphocytes / virology
  • Neutrophils / pathology
  • Neutrophils / virology
  • Pandemics
  • Patient Admission
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / diagnosis*
  • Pneumonia, Viral / mortality
  • Pneumonia, Viral / virology
  • Prognosis
  • ROC Curve
  • Retrospective Studies
  • SARS-CoV-2
  • Severe Acute Respiratory Syndrome / complications
  • Severe Acute Respiratory Syndrome / diagnosis*
  • Severe Acute Respiratory Syndrome / mortality
  • Severe Acute Respiratory Syndrome / virology
  • Shock, Septic / complications
  • Shock, Septic / diagnosis*
  • Shock, Septic / mortality
  • Shock, Septic / virology
  • Survival Analysis

Substances

  • Biomarkers
  • Calgranulin A
  • Calgranulin B
  • HMGB1 Protein
  • HMGB1 protein, human
  • S100A8 protein, human
  • S100A9 protein, human